文献速递系统性红斑狼疮

精神科诊断与治疗对青少年系统性红斑狼疮患者用药依从性的影响

Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth With Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-01-01

该研究基于美国商业保险理赔数据,纳入873例10-24岁初用羟氯喹的SLE青少年,分析精神障碍诊断与羟氯喹依从性的关联及精神科治疗的修饰作用。结果显示仅适应障碍与依从性下降独立相关,而精神科药物治疗或心理治疗可改变精神障碍对依从性的影响方向。

要点

  • 20%的SLE青少年有精神障碍诊断,最常见为抑郁。
  • 仅适应障碍独立关联羟氯喹依从性下降(β -0.12,P=0.05)。
  • 接受精神科治疗可逆转精神障碍对依从性的负面影响。

核心结论

  • 精神障碍对用药依从性的影响因是否接受精神科治疗而异,改善精神科问题的识别与治疗可能提高SLE青少年的用药依从性。

研究设计与样本

  • 利用Optum Clinformatics Data Mart(2000-2016)去标识化美国商业保险理赔数据,识别10-24岁初用羟氯喹的SLE青少年,用多变量线性回归分析精神障碍与365天药物持有率(MPR)的关联。

主要发现

  • 873例受试者中20%有精神障碍诊断,最常见为抑郁。
  • 仅适应障碍独立关联MPR下降(β -0.12,P=0.05)。
  • 在有精神障碍诊断的青少年中,使用精神药物者MPR较未使用者高0.15(交互P=0.02)。
  • 在有抑郁或焦虑的青少年中,接受心理治疗者MPR高于未接受者(交互P=0.05和P<0.01)。

临床怎么用

  • 对SLE青少年应筛查精神障碍,尤其适应障碍,并积极提供精神药物或心理治疗以改善羟氯喹依从性。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Youth with systemic lupus erythematosus (SLE) experience high rates of psychiatric comorbidities, which may affect medication adherence. We undertook this study to examine the association between psychiatric disorders and hydroxychloroquine adherence and to determine whether psychiatric treatment modifies this association. METHODS: We identified incident hydroxychloroquine users among youth with SLE (ages 10-24 years) using de-identified US commercial insurance claims in Optum Clinformatics Data Mart (2000-2016). Adherence was estimated using medication possession ratios (MPRs) over a 365-day time period. Multivariable linear regression models were used to estimate the effect of having any psychiatric disorder on MPRs, as well as the independent effects of depression, anxiety, adjustment, and other psychiatric disorders. We tested for interactions between psychiatric diagnoses and treatment with psychotropic medications or psychotherapy. RESULTS: Among 873 subjects, 20% had a psychiatric diagnosis, most commonly depression. Only adjustment disorders were independently associated with decreased MPRs (β -0.12, P = 0.05). We observed significant crossover interactions, in which psychiatric disorders had opposite effects on adherence depending on the receipt of psychiatric treatment. Among youth with any psychiatric diagnosis, psychotropic medication use was associated with a 0.15 increase in the MPR compared with no psychotropic medication use (P = 0.02 for interaction). Among youth with depression or anxiety, psychotherapy was also associated with a higher MPR compared with no psychotherapy (P = 0.05 and P < 0.01 for interaction, respectively). CONCLUSION: The impact of psychiatric disorders on medication adherence differed by whether youth had received psychiatric treatment. Improving recognition and treatment of psychiatric conditions may increase medication adherence in youth with SLE.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Chang JC, Davis AM, Klein-Gitelman MS, et al. Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021. PMID: 32937032. doi:10.1002/acr.24450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。